BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37414853)

  • 21. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma.
    Yang J; Lin P; Yang M; Liu W; Fu X; Liu D; Tao L; Huo Y; Zhang J; Hua R; Zhang Z; Li Y; Wang L; Xue J; Li H; Sun Y
    Genome Biol; 2021 Jan; 22(1):4. PubMed ID: 33397441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
    Yu Y; Wang Z; Mo DH; Wang Z; Li G
    Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
    Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H
    Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
    Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
    Front Immunol; 2022; 13():970588. PubMed ID: 36148233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer.
    Li Y; Liang X; Che G; Chen Y; Luo L; Liu K; Xie R; Zeng L
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma.
    Zhang D; Cui F; Peng L; Wang M; Yang X; Xia C; Li K; Yin H; Zhang Y; Yu Q; Jin Z; Huang H
    Aging (Albany NY); 2022 Aug; 14(15):6299-6315. PubMed ID: 35963640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
    PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of metabolic pathways could offset the poor prognosis conferred by co-existent diabetes mellitus in pancreatic (head) adenocarcinoma.
    Gardi N; Ketkar M; McKinnon RA; Pandol SJ; Dutt S; Barreto SG
    ANZ J Surg; 2021 Nov; 91(11):2466-2474. PubMed ID: 34514690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
    BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
    Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
    Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
    N Kalimuthu S; Wilson GW; Grant RC; Seto M; O'Kane G; Vajpeyi R; Notta F; Gallinger S; Chetty R
    Gut; 2020 Feb; 69(2):317-328. PubMed ID: 31201285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma.
    Aier I; Semwal R; Dhara A; Sen N; Varadwaj PK
    PLoS One; 2019; 14(10):e0223554. PubMed ID: 31622355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
    Mortoglou M; Miralles F; Arisan ED; Dart A; Jurcevic S; Lange S; Uysal-Onganer P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis.
    Yang B; Zhou M; Wu Y; Ma Y; Tan Q; Yuan W; Ma J
    Front Immunol; 2021; 12():769047. PubMed ID: 34777388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
    Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
    Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.